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A bacterial flavin-containing monooxygenase (FMO), fused
to phosphite dehydrogenase, has been used to explore its
biocatalytic potential. The bifunctional biocatalyst could be
expressed in high amounts in Escherichia coli and was able
to oxidize indole and indole derivatives into a variety of
indigo compounds. The monooxygenase also performs the
sulfoxidation of a wide range of prochiral sulfides, showing
moderate to good enantioselectivities in forming chiral sulf-
oxides.
Introduction
Flavin containingmonooxygenases (FMO) (E.C. 1.14.13.8) repre-
sent single-component ﬂavoprotein monooxygenases that contain
a tightly bound FAD cofactor.1 In their catalytic cycle, the
ﬂavin cofactor is reduced by NADPH after which it reacts with
molecular oxygen to form a hydroperoxyﬂavin intermediate.2
This reactive enzyme species is able to perform oxygenation of
heteroatom-containing compounds that are able to reach its active
site. In humans, ﬁve FMO isoforms are present that show a
tissue-speciﬁc distribution.3 The role of these oxidative enzymes
is thought to be similar to that of most human cytochrome P450
monooxygenases: detoxiﬁcation of drugs and other xenobiotics
into more hydrophilic metabolites.4 The crucial detoxifying role
of human FMOs becomes apparent when considering trimethyl-
aminuria, also known as ﬁsh-odour syndrome. This metabolic
disorder is caused by mutations in human FMO3 and results in
accumulation of trimethylamine, causing a “ﬁsh odour”.5
Most of the known FMOs have been shown to be membrane-
associated, prohibiting facile isolation. As a result, FMOs have
rarely been studied for biocatalytic purposes.6 Some years ago
the ﬁrst bacterial FMO, mFMO from Methylophaga sp. strain
SK1, was reported which was shown to be a soluble enzyme that
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could be overexpressed in E. coli.7 In fact, inspection of sequenced
bacterial genomes with the aid of an FMO-speciﬁc sequence motif
has revealed a large number of genes that putatively encode soluble
FMOs.8 Therefore it is attractive to start exploring this class of
monooxygenases.
Little biocatalytic data on mFMO have been reported. mFMO
is a homodimer with subunits of 54 kDa, showing around 30%
sequence identity with the ﬁve human FMOs.7 mFMO was shown
to be able to convert endogenous indole in E. coli cells and
this capacity has been optimized to form up to 920 mg indigo
blue per litre of fermentation broth.9 It was also shown that
the bacterial enzyme is able to convert similar substrates when
compared with human FMOs, e.g. trimethylamine and (S)-(-)-
nicotine are efﬁciently oxidized by mFMO.
Recently we have described the preparation of self-
sufﬁcient monooxygenases by covalent coupling of Baeyer–
Villiger monooxygenases (BVMOs) with the soluble NADPH-
regenerating phosphite dehydrogenase (PTDH) from Pseu-
domonas stutzeri.10 These bifunctional biocatalysts are able to
use phosphite as a cheap and sacriﬁcial substrate for recycling
NADPH. An improved expression vector for producing these
bifunctional biocatalysts has been developed using a codon-
optimized gene encoding a His-tagged and thermostable PTDH
mutant as fusion partner.11
For this exploratory biocatalytic study on mFMO, we have
used this newly developed expression vector. The produced self-
sufﬁcient mFMO was explored for the preparation of chiral sulf-
oxides, target molecules with a high interest due to their biological
properties and widespread applications in organic synthesis.12
Furthermore, we looked into the applicability of mFMO for the
preparation of indigo derivatives, valuable as dyes or precursors
for pharmaceuticals,13 which have been targeted before with other
monooxygenases with varying degrees of success.14
Results and discussion
The fused PTDH-mFMO could be readily expressed as soluble
and bifunctional enzyme at high levels. By a one-step puriﬁcation,
102mgof pure and soluble PTDH-mFMOcould be obtained from
1.0 L of culture broth. The bifunctional biocatalyst was tested for
activity at several temperatures with trimethylamine. This revealed
that the optimal temperature for activity is 70 ◦C. However, at this
temperature the enzyme is quickly inactivated with a total loss





























































of activity after 2 min. Analysis of the thermostability at 35 ◦C
revealed a half-life of 5 h for mFMO, without affecting the activity
of PTDH. For further experiments, it was decided to perform
conversions at 25 ◦C. It was also established that the enzyme was
most effective at pH 9.0 (see Supporting Information†).
It is known thatmFMO is able to form indigo blue from indole.7
This was also clearly visible when growing cells for PTDH-mFMO
overproduction: the growthmedium turned dark blue. To establish
whether mFMO can also be used for synthesis of other indigo
derivatives, isolated PTDH-mFMOwas incubated with a range of
indole derivatives. Visual inspection revealed that all tested indoles
were accepted as substrate as evidenced by formation of a variety
of colors (Fig. 1). By steady-state kinetic analysis the reaction
rates for all indole derivatives were determined (see Supporting
Information). Indole was found to be converted most efﬁciently.
Fig. 1 PTDH-mFMO catalyzed oxidation of indole and indole deriva-
tives into indigoid dyes.
As mFMO has been shown to convert indoles, a set of
substituted aromatic sulﬁdes was tested as substrates. Most of
the tested sulﬁdes were shown to be oxidized and exhibited quite
good KM values, ranging from 100 to 600 mM, while the kcat values
were only modest: ~0.5 s-1 (see Supporting Information†). PTDH-
mFMO was subsequently assayed for enantioselective oxidation
of thioanisole derivatives (Table 1). Reactions were performed in
Tris-HCl buffer which contained 1% DMSO in order to dissolve
the sulﬁdes. Inmost cases, the (S)-sulfoxides were formed in excess.
The most effective conversion was found with thioanisole 1a,
yielding 95% of (S)-methyl phenyl sulfoxide 1b after 8 h, albeit
with a moderate enantiomeric excess (ee = 35%). Substituents in
the aromatic ring decreased the enzymatic activity. PTDH-mFMO
was able to oxidize methyl p-tolyl sulﬁde (4a) and p-chlorophenyl
methyl sulﬁde (5a) into the corresponding sulfoxides (S)-4–5bwith
high enantiomeric excesses (ee>90%). Good enantioselectivities
were also obtained in the oxidation of the p-hydroxy (2a), p-
methoxy (3a) and o-chloro (7a) derivatives, while the chloro-
substitution in the meta-position (6a) as well as the presence of
electron-withdrawing groups (8–10a) had a negative effect on the
selectivity of the formed sulfoxide.
As well as oxidation of thioanisole derivatives, some other
aromatic sulﬁdes were also tested. As indicated in Table 2, the
Table 1 Sulfoxidation of thioanisole derivatives catalyzed by PTDH-
mFMOa
Sulﬁde X Time (h) Conv. (%)b ee (%)c
1a H 8 95 35 (S)
2a p-OH 15 37 81 (S)
3a p-OMe 15 78 70 (S)
4a p-Me 15 66 92 (S)
5a p-Cl 15 80 95 (S)
6a m-Cl 15 69 15 (R)
7a o-Cl 15 81 75 (R)
8a p-COMe 15 8 21 (R)
9a p-CN 15 50 22 (S)
10a p-NO2 15 47 37 (S)
a For reaction details, see Experimental. b Measured byGC. c Enantiomeric
excesses measured by HPLC.
oxidation of phenyl ethyl sulﬁde (11a) and its propyl analogue
(12a) led to a signiﬁcant loss in conversion when compared to
thioanisole, but the corresponding (S)-sulfoxides can be obtained
with much better enantiomeric excess (ee = 79%). (S)-Benzyl
methyl sulfoxide (S)-13b and the ethyl derivative 14b were formed
with excellent or good conversions, respectively, while the biocata-
lyst showed a poor enantioselectivity for these compounds. When
the sulfur atom was further away from the phenyl moiety (15a)
a good enzymatic activity and moderate enantioselectivity was
observed. No oxidation was achieved for those sulﬁdes presenting
one (methyl naphthyl sulﬁde, 16a) or two bulky substituents
(benzyl phenyl sulﬁde, 17a). PTDH-mFMOhas also been tested in
the synthesis of heteroaromatic chiral sulfoxides, important chiral
auxiliaries in asymmetric catalysis. Methyl 2-pyridyl sulﬁde, 2-
furfurylmethyl methyl sulﬁde and 2-(methylthio)thiophene were
converted into the corresponding sulfoxides with high conversions
(around 80%). (S)-18b and (S)-20b were obtained with moderate
enantiomeric excess, while the formation of (R)-l9b occurred with
a low selectivity.
As mFMO has been shown to be active on aliphatic amines,
PTDH-mFMOwas also tested with several aliphatic sulﬁdes. This
has revealed that it displays a relatively low activity and selectivity
for the oxidation of cycloalkyl alkyl sulﬁdes (21a). Sulfoxidation of
tetrahydro-2H-thiopyran (22a) did not take place, even after long
reaction times. Finally, we focused on the biooxidation of linear
aliphatic sulﬁdes. It was found that alkyl butyl sulﬁdes 23a and 24a
were oxidized with moderate conversion and good enantiomeric
excesses in order to obtain (R)-23b and (R)-24b, respectively. The
presence of a longer alkyl chain in the sulﬁde structure had a
negative effect on the reactivity, as no reaction was observed in the
oxidation of n-octyl methyl sulﬁde 25a.
PTDH-mFMO was also tested in the oxidation of racemic
sulfoxides. Incubating racemic methyl phenyl sulfoxide (±)-1bwith
this biocatalyst led to a moderate conversion, with only 8% of the
ﬁnal sulfone while 1b remained racemic. No sulfoxide oxidation
was observed for compounds (±)-4b, (±)-5b and (±)-7b after long
reaction times.





























































Table 2 PTDH-mFMO catalyzed synthesis of chiral sulfoxides starting
from the corresponding sulﬁdea
Sulﬁde Sulfoxide Time (h) Conv. (%)b ee (%)c
11a 15 15 79 (S)
12a 24 12 71 (S)
13a 8 91 17 (S)
14a 8 75 15 (S)
15a 15 80 36 (S)
18a 15 83 49 (S)
19a 15 72 20 (R)
20a 15 76 50 (S)
21a 15 14 20 (R)
23a 15 52 85 (R)
24a 15 71 77 (R)
a For reaction details, see Experimental. b Measured byGC. c Enantiomeric
excesses measured by HPLC.
The close homology of FMOs and BVMOs1 inspired us to
test substrates that are readily oxidized by the latter type of
enzymes.However, after long reaction times, no product formation
was observed in the presence of different ketones (2-octanone,
cyclohexanone and acetophenone) or phenylboronic acid.
In a previous report, the inﬂuence of the organic cosolvents on
the oxidation of prochiral sulﬁdes catalyzed by BVMOs has been
described.15 Short alkyl chain alcohols as cosolvents were shown
to result in an increase or even a reversal in enantioselectivity for
some BVMOs. To probe this effect on mFMO, oxidation of 1a
was performed in the presence of several organic cosolvents (5%
v/v) with different physico-chemical properties. All the cosolvents
tested led to lower conversions and/or enantiomeric excesses (see
Supporting Information†), with the exception of the reaction in
5% hexane. For this cosolvent, (S)-1b was recovered with a 48% ee
and62%extent,while 28%ofmethyl phenyl sulfone 1cwas formed.
Sulfoxidation with a combination of 1% DMSO and 5% hexane
occurred only with 24% conversion and 34% ee for (S)-1b. From
Table 3 Effect of hexane in the sulfoxidation of 1a and (±)-1ba
Entry Compound Cosolvent Conv. (%)b ee (%)c
1 1a None 48 (2) 33
2 1a 1% DMSO 95 (5) 35
3 1a 5% Hexane 90 (28) 48
4 1a 5% Hexane 24 34
1% DMSO
5 1a 3 mM OctNH2 76 (7) 27
6 (±)-1b 1% DMSO 8 5
7 (±)-1b 5% Hexane 61 72
8 (±)-1b 5% Hexane 9 5
1% DMSO
a Reaction time 8 h. For other reaction details, see Experimental.
b Measured by GC. Amount of sulfone in brackets. c Measured by HPLC.
the data it becomes clear that 5%hexane has an activating effect on
the oxidation of the sulfoxide 1b, while the presence of DMSO in
the reaction medium inhibits sulfoxide oxidation, as can be shown
in the experiments developed by employing PTDH-mFMO in the
biooxidation of (±)-1b (entries 6–8, Table 3). Thus, the increase in
the enantiomeric excess observed when working in 5% hexane is
due to the desymmetrization of prochiral 1a combined with the
kinetic resolution of 1b. n-Hexane presents a somewhat similar
structure to 1-octylamine, which has been described as a speciﬁc
activator in humanFMOs.16 The presence of 3mMof this additive
led to a higher conversion while it did not signiﬁcantly affect the
enantioselectivity (see entry 5).
In order to show that this bifunctional enzyme can be used as
an effective biocatalyst, we set up a semipreparative experiment,
in which sulﬁde 5a was used as model substrate. Sulfoxidation was
performed by incubating 100 mg of prochiral 5a in the presence
of PTDH-mFMO (4.0 mM), sodium phosphite as cosubstrate,
NADPH (0.2 mM) and dioxygen as oxidant. After 24 h, (S)-5b
was achieved with a 90% conversion and 95% enantiomeric excess.
The sulfoxide product was isolated by column chromatography, to
afford 77% isolated yield.
Conclusions
A novel fused oxidative biocatalyst has been overexpressed in
E. coli, isolated and puriﬁed. PTDH-mFMO was found to be
able to oxidize indole and analogues into the corresponding
indigoid pigments which represent interesting dyes and bioactive
compounds. The bifunctional dehydrogenase-FMO system has
been applied for the ﬁrst time in the biocatalysed sulfoxidation of
prochiral sulﬁdes. Depending on the substrate structure, excellent
enantioselectivities can be achieved. The data show that bacterial
FMOs represent an unexplored and interesting class of oxidative
biocatalysts which may be of use for synthetic purposes. The
availability of the crystal structure of mFMO2a can also facilitate
redesign of FMOs for speciﬁc biocatalytic applications.
Experimental
Recombinant PTDH-mFMO was overexpressed and puriﬁed
following the previously described procedure.10 1.0Unit of PTDH-
mFMO will oxidize 1.0 mmol of thioanisole to methyl phenyl
sulfoxide per minute at pH 9.0 and room temperature in the
presence of NADPH. Starting prochiral sulﬁdes 1a, 6a, 8a were





























































purchased from Sigma–Aldrich–Fluka, 2–5a, 7a, 9–10a, 11a, 16a,
17a, 19a, 20a and 21a were supplied by Alfa Aesar, 13a, 22a,
23a and 24a were obtained from Acros Organics and compound
25a was a product by TCI Europe. All the starting indoles were
products from Sigma-Aldrich-Fluka, with the exception of 4-
chloroindole, whichwas purchased fromAcrosOrganics. All other
reagents and solvents were of the highest quality grade available.
Chemical reactions were monitored by analytical TLC, per-
formed on silica gel 60 F254 plates and visualized by UV
irradiation. Flash chromatography was carried out with silica gel
60 (230–240 mesh). Kinetic parameters were measured in a Varian
Cary50BioUV/Vis spectrophotometer.Melting pointswere taken
on samples in open capillary tubes and are uncorrected. IR
spectra were recorded on infrared spectrophotometer using KBr
pellets. 1H-NMR, 13C-NMR and DEPT spectra were recorded
with tetramethylsilane (TMS) as the internal standard with aDPX
(1H: 300.13MHz; 13C: 75.5MHz) spectrometer. The chemical shift
values (d) are given in ppm.Optical rotations weremeasured using
a polarimeter and are quoted in units of 10-1 deg cm2 g-1. APCI+
and ESI+ using a chromatograph mass detector or EI+ with a
mass spectrometer were used to record mass spectra (MS). High-
resolution mass spectra were obtained with a Bruker Microtof-Q-
spectrometer.
Methyl phenylethyl sulﬁde 15a was synthesized by treating at
0 ◦C the corresponding thiol with sodium and methyl iodide
in dry MeOH, under a nitrogen atmosphere (40% yield).17 2-
(Methylthio)pyridine 18a was prepared by reaction of the cor-
responding thiol and potassium carbonate with iodomethane and
triethylamine in CH2Cl2 at 0 ◦C (99% yield).18 p-Acetoxyphenyl
methyl sulﬁde 2c was obtained from 2a by acetylation in presence
of acetic anhydride and pyridine (90% yield). Racemic sulfoxides
(±)-1–15b, (±)-18–21b and (±)-23–24b were prepared by chemical
oxidation of the corresponding sulﬁdes employing hydrogen per-
oxide and methanol (yields higher than 60%). All the synthesised
compounds 15a,19a 18a,18 1b,17 2b,19b 3–7b,17 8b,19c 9–15b,17 18b,19d
19b,19e 20b,19f 21b,19d 23b,19g 24b19d exhibited physical and spectral
data in agreement with those reported.
Absolute conﬁgurations of sulfoxides 1b,17 3–7b,17 9–15b,17
18b,20a 19b,20b 20b,20a 21b19e were determined by comparison of
elution order on HPLC with published data, meanwhile the
absolute conﬁgurations of sulfoxide 2b and 8b were established
by comparing the retention times on HPLC for acetylated 2b
and 8b with the ones obtained in the asymmetric sulfoxidations
of prochiral sulﬁdes 2c and 8a employing (+)-diethyl L-tartrate,
Ti(O-i-Pr)4 and TBHP.21 The absolute conﬁguration of compound
23b was obtained by comparing the speciﬁc rotation value with
published data,22 while absolute conﬁguration of butyl ethyl
sulfoxide 24b was established by analogy with this latest one.
General procedure for the oxidation of indole and derivatives
employing PTDH-mFMO
A plate with 24 wells was employed. A solution of the corre-
sponding starting indoles (5.0 mM) was dissolved in Tris-HCl
buffer 50 mM, 35mMNaCl, pH 8.5 containing sodium phosphite
(10 mM), NADPH (0.2 mM) and self-sufﬁcient biocatalyst
PTDH-mFMO (4 mM). Reactions were stirred at 25 ◦C for 18 h
and products formation was observed colorimetrically.
General procedure for the PTDH-mFMO biocatalysed
sulfoxidations
Unless otherwise stated, prochiral sulﬁdes 1–25a (5 mM) were
dissolved in a 50 mM Tris-HCl buffer pH 9.0 (1.0 mL) containing
1% DMSO, sodium phosphite (10 mM), NADPH (0.2 mM) and
the self-sufﬁcient biocatalyst PTDH-mFMO (4 mM). Reactions
were stirred at 25 ◦C and 250 rpm for the times established.
Reactions were then stopped, extracted with EtOAc (2 ¥ 0.5 mL),
dried onto MgSO4 and analyzed by GC and/or HPLC in order
to determine the conversions and the enantiomeric excesses of
the sulfoxides (R)- or (S)-1–25b. Control reactions in absence of
biocatalyst were performed and did not result in any conversion.
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